高级检索
当前位置: 首页 > 详情页

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

文献详情

资源类型:
Pubmed体系:
机构: [1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Sichuan Luzhou 646600, China. [2]Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Sichuan Luzhou, 646000, China. [3]South Sichuan Institute of Translational Medicine, Sichuan Luzhou 646600, China. [4]School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. [5]Department of Oncology, Affiliated Hospital of Southwest Medical University, Sichuan Luzhou 646600, China.
出处:
ISSN:

关键词: ros tumor microenvironment molecule metabolism therapy

摘要:
Reactive oxygen species (ROS) are a class of highly reactive oxidizing molecules, including superoxide anion (O2•-) and hydrogen peroxide (H2O2), among others. Moderate levels of ROS play a crucial role in regulating cellular signaling and maintaining cellular functions. However, abnormal ROS levels or persistent oxidative stress can lead to changes in the tumor microenvironment (TME) that favor cancer development. This review provides an overview of ROS generation, structure, and properties, as well as their effects on various components of the TME. Contrary to previous studies, our findings reveal a dual effect of ROS on different components of the TME, whereby ROS can either enhance or inhibit certain factors, ultimately leading to the promotion or suppression of the TME. For example, H2O2 has dual effects on immune cells and non-cellular components within the TME, while O2•- has dual effects on T cells and fibroblasts. Furthermore, each component demonstrates distinct mechanisms of action and ranges of influence. In the final section of the article, we summarize the current clinical applications of ROS in cancer treatment and identify certain limitations associated with existing therapeutic approaches. Therefore, this review aims to provide a comprehensive understanding of ROS, highlighting their dual effects on different components of the TME, and exploring the potential clinical applications that may pave the way for future treatment and prevention strategies.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 3 区 药物化学 3 区 药学
最新[2023]版
大类 | 4 区 医学
小类 | 3 区 生化与分子生物学 3 区 药物化学 3 区 药学
第一作者:
第一作者机构: [1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Sichuan Luzhou 646600, China. [2]Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Sichuan Luzhou, 646000, China.
通讯作者:
通讯机构: [1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Sichuan Luzhou 646600, China. [2]Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Sichuan Luzhou, 646000, China. [3]South Sichuan Institute of Translational Medicine, Sichuan Luzhou 646600, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号